Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling

International Journal of Oncology

Volumn 41, Issue 1, 2012, Pages 292-298

  Wu, Ke ^a   Yang, Qiujun ^a   Mu, Yuqin ^a   Zhou, Longyang ^a   Liu, Yinzi ^a   Zhou, Qixin ^a   He, Baicheng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Berberine; Colon cancer; Proliferation inhibition; Wnt catenin signaling

Indexed keywords

BERBERINE; BETA CATENIN; DEXTRAN SULFATE; DIMETHYLHYDRAZINE; MESSENGER RNA; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT DURATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BERBERINE; BETA CATENIN; CASPASE 3; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DEXTRAN SULFATE; DIMETHYLHYDRAZINES; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; GENES, REPORTER; HCT116 CELLS; HUMANS; LUCIFERASES, FIREFLY; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; WNT SIGNALING PATHWAY;

EID: 84861683233     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1423     Document Type: Article

References (32)

1. Kinzler KW and Vogelstein B: Lessons from hereditary colo-rectal cancer. Cell 87: 159-170, 1996.
2. Aggarwal S and Chu E: Current therapies for advanced colorectal cancer. Oncology 19: 589-595, 2005. (Pubitemid 350042589)
3. Cragg GM, Grothaus PG and Newman DJ: Impact of natural products on developing new anti-cancer agents. Chem Rev 109: 3012-3043, 2009.
4. Ji HF, Li XJ and Zhang HY: Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Rep 10: 194-200, 2009.
5. da Rocha AB, Lopes RM and Schwartsmann G: Natural products in anticancer therapy. Curr Opin Pharmacol 1: 364-369, 2001. (Pubitemid 33585985)
6. Mann J: Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer 2: 143-148, 2002.
7. Koehn FE and Carter GT: The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4: 206-220, 2005. (Pubitemid 40372555)
8. Corson TW and Crews CM: Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 130: 769-774, 2007. (Pubitemid 47332575)
9. Tang J, Feng Y, Tsao S, Wang N, Curtain R and Wang Y: Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J Ethnopharmacol 126: 5-17, 2009.
10. He BC, Chen L, Zuo GW, et al: Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. Clin Cancer Res 16: 2235-2245, 2010.
11. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y and Ueno K: A combined assay of cell viability and in vitro cytotoxi-city with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 19: 1518-1520, 1996. (Pubitemid 26403266)
12. Stepanovic S, Vukovic D, Dakic I, Savic B and Svabic-Vlahovic M: A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 40: 175-179, 2000. (Pubitemid 30107900)
13. Haydon RC, Zhou L, Feng T, et al: Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res 8: 1288-1294, 2002. (Pubitemid 34517670)
14. Onose J, Imai T, Hasumura M, Cho YM and Hirose M: A new medium-term rat colon bioassay applying neoplastic lesions as endpoints for detection of carcinogenesis modifiers - validation with known modifiers. Cancer Lett 232: 272-278, 2006. (Pubitemid 43170977)
15. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95: 2509-2514, 1998. (Pubitemid 28145972)
16. Davidson G and Niehrs C: Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol 20: 453-460, 2010.
17. Silva AK, Yi H, Hayes SH, Seigel GM and Hackam AS: Lithium chloride regulates the proliferation of stem-like cells in retinoblastoma cell lines: a potential role for the canonical Wnt signaling pathway. Mol Vis 16: 36-45, 2010.
18. Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA and Das BC: Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer 10: 39, 2011.
19. Liu Q, Jiang H, Liu Z, et al: Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. PLoS One 6: e23427, 2011.
20. Yang IW, Chou CC and Yung BY: Dose-dependent effects of berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells. Naunyn Schmiedebergs Arch Pharmacol 354: 102-108, 1996. (Pubitemid 26248248)
21. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S and Fujiwara H: Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 66: 227-233, 1999. (Pubitemid 29307925)
22. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S and Fujiwara H: Inhibition of activator protein 1 activity by berberine in human hepatoma cells. Planta Med 65: 381-383, 1999. (Pubitemid 29249921)
23. Wang DY, Yeh CC, Lee JH, Hung CF and Chung JG: Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells. Neurochem Res 27: 883-889, 2002.
24. Lin JG, Chung JG, Wu LT, Chen GW, Chang HL and Wang TF: Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. Am J Chin Med 27: 265-275, 1999.
25. Iizuka N, Hazama S, Yoshimura K, et al: Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma. Int J Cancer 99: 286-291, 2002. (Pubitemid 34309488)
26. Chung JG, Wu LT, Chu CB, et al: Effects of berberine on arylamine N-acetyltransferase activity in human bladder tumour cells. Food Chem Toxicol 37: 319-326, 1999. (Pubitemid 29335759)
27. Chan CP, But PP and Ho JW: Induction of rcl, a novel growth-related gene by coptidis rhizoma in rat H4IIE cells. Life Sci 70: 1691-1699, 2002. (Pubitemid 34178376)
28. Zhang X, Gu L, Li J, et al: Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res 70: 9895-9904, 2010.
29. Hur JM, Hyun MS, Lim SY, Lee WY and Kim D: The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells. J Cell Biochem 107: 955-964, 2009.
30. Fukutake M, Yokota S, Kawamura H, et al: Inhibitory effect of Coptidis Rhizoma and Scutellariae Radix on azoxymethane-induced aberrant crypt foci formation in rat colon. Biol Pharm Bull 21: 814-817, 1998. (Pubitemid 28407226)
31. Tucker E, Buda A, Janghra B, et al: Abnormalities of the cadherin-catenin complex in chemically-induced colorectal carcinogenesis. Proc Nutr Soc 62: 229-236, 2003. (Pubitemid 36569834)
32. Imai T, Fukuta K, Hasumura M, et al: Significance of inflammation- associated regenerative mucosa characterized by Paneth cell metaplasia and beta-catenin accumulation for the onset of colorectal carcinogenesis in rats initiated with 1,2-dimethyl-hydrazine. Carcinogenesis 28: 2199-2206, 2007. (Pubitemid 47543382)